Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain August 1, 2011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects June 15, 2011
In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin 2A Receptor Binding in MDMA and Hallucinogen Users June 6, 2011
Consumption of Ayahuasca by Children and Pregnant Women: Medical Controversies and Religious Perspectives April 8, 2011
The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations March 1, 2011
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs February 15, 2011
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens January 20, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer January 3, 2011
